Patency rates of hepatic arterial resection and revascularization in locally advanced pancreatic cancer. Issue 11 (November 2022)
- Record Type:
- Journal Article
- Title:
- Patency rates of hepatic arterial resection and revascularization in locally advanced pancreatic cancer. Issue 11 (November 2022)
- Main Title:
- Patency rates of hepatic arterial resection and revascularization in locally advanced pancreatic cancer
- Authors:
- Alva-Ruiz, Roberto
Abdelrahman, Amro M.
Starlinger, Patrick P.
Yonkus, Jennifer A.
Moravec, David N.
Busch, Joel J.
Fleming, Chad J.
Andrews, James C.
Mendes, Bernardo C.
Colglazier, Jill J.
Smoot, Rory L.
Cleary, Sean P.
Nagorney, David M.
Kendrick, Michael L.
Truty, Mark J. - Abstract:
- Abstract: Background: Arterial resection (AR) for pancreatic adenocarcinoma is increasingly considered at specialized centers. We aimed to examine the incidence, risk factors, and outcomes of hepatic artery (HA) occlusion after revascularization. Methods: We included patients undergoing HA resection with interposition graft (IG) or primary end-to-end anastomoses (EE). Complete arterial occlusion (CAO) was defined as "early" (EO) or "late" (LO) before/after 90 days respectively. Kaplan–Meier and change-point analysis for CAO was performed. Results: HA resection was performed in 108 patients, IG in 61% (66/108) and EE in 39% (42/108). An equal proportion (50%) underwent HA resection alone or in combination with celiac and/or superior mesenteric artery. CAO was identified in 18% of patients (19/108) with arterial IG least likely to occlude (p= 0.019 ). Hepatic complications occurred in 42% (45/108) and correlated with CAO, symptomatic patients, venous resection, and postoperative portal venous patency. CAO-related operative mortality was 4.6% and significantly higher in EO vs LO ( p = 0.046). Median CAO occlusion was 126 days. With change-point analysis, CAO was minimal beyond postoperative day 158. Conclusion: CAO can occur in up to 18% of patients and the first 5-month post-operative period is critical for surveillance. LO is associated with better outcomes compared to EO unless there is inadequate portal venous inflow.
- Is Part Of:
- HPB. Volume 24:Issue 11(2022)
- Journal:
- HPB
- Issue:
- Volume 24:Issue 11(2022)
- Issue Display:
- Volume 24, Issue 11 (2022)
- Year:
- 2022
- Volume:
- 24
- Issue:
- 11
- Issue Sort Value:
- 2022-0024-0011-0000
- Page Start:
- 1957
- Page End:
- 1966
- Publication Date:
- 2022-11
- Subjects:
- Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
616.362005 - Journal URLs:
- https://www.journals.elsevier.com/hpb/ ↗
http://www.hpbonline.org/current ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1477-2574 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1016/j.hpb.2022.06.005 ↗
- Languages:
- English
- ISSNs:
- 1365-182X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4335.262340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24216.xml